6609 — Shanghai HeartCare Medical Technology Share Price
0.000.00%
Last trade - 00:00- HK$650.86m
- -HK$90.72m
- CNY232.34m
- 34
- 32
- 22
- 14
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 84.91 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.56 | ||
| Price to Tang. Book | 0.58 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.59 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -8.83% | ||
| Return on Equity | -8.39% | ||
| Operating Margin | -43.37% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | n/a | 14.56 | 90.09 | 183.03 | 232.34 | 342.44 | 461.9 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Shanghai HeartCare Medical Technology Corp Ltd is a China-based company engaged in the research and development of innovative neuro-interventional medical device. The Company's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The Company's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The Company's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The Company distributes its products within the domestic market.
Directors
- Guohui Wang CHM (43)
- Han Zhang CFO (33)
- Kun Zhang DGM (43)
- Zhigang Li DGM (59)
- Jiawei Wei DGM (43)
- Wai Ki Au-yeung SEC (57)
- Gang Chen NED
- Kui Ding NED (38)
- Xiangyu Ouyang NED (55)
- Xiangqian Feng NID (34)
- Ping Gong NID (33)
- Shaomu Guo NID (54)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 16th, 2016
- Public Since
- August 20th, 2021
- No. of Employees
- 368
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 38,834,408
- Address
- 1F and 3F, Building 38, SHANGHAI, 201201
- Web
- http://www.heartcare.com.cn/
- Phone
- +86 2158975055
- Auditors
- Ernst & Young
Upcoming Events for 6609
Similar to 6609
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
What is the Shanghai HeartCare Medical Technology share price?
As of Today at 19:10 UTC, shares in Shanghai HeartCare Medical Technology are trading at HK$16.76. This share price information is delayed by 15 minutes.
How has the Shanghai HeartCare Medical Technology share price performed this year?
Shares in Shanghai HeartCare Medical Technology last closed at HK$16.76 and the price had moved by -57.62% over the past 365 days. In terms of relative price strength the Shanghai HeartCare Medical Technology share price has underperformed the FTSE Developed Asia Pacific Index by -57.33% over the past year.
What are the analyst and broker recommendations for Shanghai HeartCare Medical Technology?
The overall consensus recommendation for Shanghai HeartCare Medical Technology is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Shanghai HeartCare Medical Technology dividend yield?
Shanghai HeartCare Medical Technology does not currently pay a dividend.
Does Shanghai HeartCare Medical Technology pay a dividend?
Shanghai HeartCare Medical Technology does not currently pay a dividend.
When does Shanghai HeartCare Medical Technology next pay dividends?
Shanghai HeartCare Medical Technology does not currently pay a dividend.
How do I buy Shanghai HeartCare Medical Technology shares?
To buy shares in Shanghai HeartCare Medical Technology you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Shanghai HeartCare Medical Technology?
As of the previous close price of HK$16.76, shares in Shanghai HeartCare Medical Technology had a market capitalisation of HK$650.86m.
Where are Shanghai HeartCare Medical Technology shares listed?
Here are the trading details for Shanghai HeartCare Medical Technology:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 6609
What kind of share is Shanghai HeartCare Medical Technology?
Based on an overall assessment of its quality, value and momentum Shanghai HeartCare Medical Technology is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Shanghai HeartCare Medical Technology share price forecast for 2024?
The analyst consensus target price for shares in Shanghai HeartCare Medical Technology is HK$29.37. That is 75.26% above the last closing price of HK$16.76.
Analysts covering Shanghai HeartCare Medical Technology currently have a consensus Earnings Per Share (EPS) forecast of -CNY0.04 for the next financial year.
What is the trend in the Shanghai HeartCare Medical Technology share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shanghai HeartCare Medical Technology. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -40.4%.
As of the last closing price of HK$16.76, shares in Shanghai HeartCare Medical Technology were trading -33.15% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Shanghai HeartCare Medical Technology PE Ratio?
The Shanghai HeartCare Medical Technology PE ratio based on its reported earnings over the past 12 months is 84.91. The shares last closed at HK$16.76.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Shanghai HeartCare Medical Technology?
Shanghai HeartCare Medical Technology's management team is headed by:
- Guohui Wang - CHM
- Han Zhang - CFO
- Kun Zhang - DGM
- Zhigang Li - DGM
- Jiawei Wei - DGM
- Wai Ki Au-yeung - SEC
- Gang Chen - NED
- Kui Ding - NED
- Xiangyu Ouyang - NED
- Xiangqian Feng - NID
- Ping Gong - NID
- Shaomu Guo - NID